The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

38 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
39
Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies.EBI
University of Karachi
25
Synthesis, alkaline phosphatase inhibition studies and molecular docking of novel derivatives of 4-quinolones.EBI
Universit£T Rostock
30
2-Alkoxy-3-(sulfonylarylaminomethylene)-chroman-4-ones as potent and selective inhibitors of ectonucleotidases.EBI
Forman Christian College (A Chartered University)
21
Diarylsulfonamides and their bioisosteres as dual inhibitors of alkaline phosphatase and carbonic anhydrase: Structure activity relationship and molecular modelling studies.EBI
Forman Christian College (A Chartered University)
25
Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.EBI
Sanford-Burnham Medical Research Institute
54
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes.EBI
Sanford-Burnham Medical Research Institute
21
Identification of novel chromone based sulfonamides as highly potent and selective inhibitors of alkaline phosphatases.EBI
Forman Christian College (A Chartered University)
22
Alkaline phosphatase inhibition by a series of pyrido[2,1-b]quinazolines: A possible relationship with cromolyn-like antiallergy activity.EBI
TBA
1
Synthesis and evaluation of thiophenyl derivatives as inhibitors of alkaline phosphatase.EBI
University of Lyon 1
36
Design and synthesis of selective inhibitors of placental alkaline phosphatase.EBI
Human Biomolecular Research Institute
1
Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.EBI
University of Lyon
22
Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).EBI
Institute For Medical Research
31
Design and synthesis of pyrazole derivatives as potent and selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP).EBI
Institute For Medical Research
37
Unveiling sultam in drug discovery: spotlight on the underexplored scaffold.EBI
Monash University
53
Targeting ecto-5'-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators.EBI
Federal University of Rio Grande Do Sul
2
Specific Inhibitor of Placental Alkaline Phosphatase Isolated from a DNA-Encoded Chemical Library Targets Tumor of the Female Reproductive Tract.EBI
Swiss Federal Institute of Technology (Eth Z£Rich)
13
A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.EBI
Utah State University
23
Exploration of carboxy pyrazole derivatives: Synthesis, alkaline phosphatase, nucleotide pyrophosphatase/phosphodiesterase and nucleoside triphosphate diphosphohydrolase inhibition studies with potential anticancer profile.EBI
Quaid-I-Azam University
17
Hybrid compounds from chalcone and 1,2-benzothiazine pharmacophores as selective inhibitors of alkaline phosphatase isozymes.EBI
University of Auckland
31
2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.EBI
Universit£T Rostock
35
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.EBI
Sanford Burnham Prebys Medical Discovery Institute
234
INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCERBDB
Merck Patent
104
Farnesoid X receptor agonists and uses thereofBDB
Metacrine
212
Factor IXa inhibitorsBDB
Merck Sharp & Dohme
84
Spirocyclic derivativesBDB
Chronos Therapeutics
143
Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disordersBDB
Bayer
411
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseBDB
Lycera
238
Heterocyclic inhibitors of MCT4BDB
Vettore
2
Thienopyrimidine compounds and use thereofBDB
Takeda Pharmaceutical
36
Cannabinoid-2 agonistsBDB
Allergan
47
Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitorsBDB
The Medicines Company (Leipzig)
10
Identification and Characterization of a New Chemotype of Noncovalent SENP Inhibitors.BDB
Beckman Research Institute of The City of Hope
11
A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease.BDB
National Cancer Institute At Frederick
12
Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry.BDB
The Scripps Research Institute
7
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.BDB
The Scripps Research Institute
26
N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.BDB
Gnf
21
Binding thermodynamics of substituted diaminopyrimidine renin inhibitors.BDB
Pfizer
29
Discovery of the HCV NS3/4A protease inhibitor (1R,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3- [2(S)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]- 6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (Sch 503034) II. Key steps in structure-based optimization.BDB
Schering-Plough Research Institute